Insulet Corp.
PODD
Kedudukan dalam Saham
#2066
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Harga Saham
$143.29
Modal Pasaran
$9.94B
Perubahan (1 hari)
0.94%
Perubahan (1 tahun)
-56.16%
Negara
US
Perdagangan Insulet Corp. (PODD)
Kategori
Healthcare
Hasil untuk Insulet Corp. (PODD)
Hasil pada Jun 2026 TTM: $3.05B
Menurut laporan kewangan terkini daripada Insulet Corp., hasil semasa syarikat (TTM) ialah $3.05B. Pada tahun 2023, syarikat memperoleh hasil sebanyak $1.70B peningkatan berbanding hasil pada tahun 2022 iaitu $1.31B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Insulet Corp. dari 2002 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $3.05B | 47.40% |
| 2024 | $2.07B | 22.07% |
| 2023 | $1.70B | 30.02% |
| 2022 | $1.31B | 18.79% |
| 2021 | $1.10B | 21.49% |
| 2020 | $904.40M | 22.51% |
| 2019 | $738.20M | 30.93% |
| 2018 | $563.82M | 21.57% |
| 2017 | $463.77M | 26.37% |
| 2016 | $366.99M | 39.07% |
| 2015 | $263.89M | -8.60% |
| 2014 | $288.72M | 16.85% |
| 2013 | $247.08M | 16.90% |
| 2012 | $211.37M | 38.83% |
| 2011 | $152.26M | 57.02% |
| 2010 | $96.97M | 46.85% |
| 2009 | $66.03M | 83.12% |
| 2008 | $36.06M | 169.66% |
| 2007 | $13.37M | 265.06% |
| 2006 | $3.66M | 7,226.00% |
| 2005 | $50.00K | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $46.59B | 1,425.63% |
US
|
|
| $35.48B | 1,062.08% |
IE
|
|
| $25.84B | 746.14% |
US
|
|
| $21.00B | 587.60% |
US
|
|
| - | - |
DE
|
